For MS-DRG 168, there are 65 cases reporting a principal diagnosis of PE and USAT procedure with the administration of thrombolytic(s) and 15 cases reporting a principal diagnosis of PE and USAT procedure without the administration of thrombolytic(s), however, both subsets of cases have a similar average length of stay (2.8 days and 2.7 days, respectively) with a difference in average costs of $44 ($20,156$20,112 = $44)
Multi-use: Draw multiple doses from a single vial under sterile conditions
In models of NO-system disruption, BPC-157 appeared to rescue vascular and wound-healing responses
The antioxidant is especially abundant in mitochondria, which cannot function without it
There is not yet reliable clinical-trial evidence showing that BPC-157 heals tendon, ligament or muscle injuries in people
(Expert opinion varies over what degree of legal risk if any physicians face for prescribing peptides like BPC-157